What is Lynparza?
Lynparza is a targeted cancer drug known as a poly (ADP-ribose) polymerase (PARP) inhibitor. This prescription medication is used to treat adults with certain types of advanced cancers. These include ovarian, breast, pancreatic, and prostate cancers. Lynparza is specifically for patients whose cancer has a certain genetic mutation. It offers a modern approach to cancer treatment by focusing on the cancer cells’ specific weaknesses. This drug is often used after other treatments have been tried.
How does Lynparza work?
Lynparza works by blocking an enzyme in your body called PARP. Cancer cells rely on PARP to help repair their own damaged DNA. By blocking this enzyme, Lynparza prevents the cancer cells from fixing themselves. This causes the cancer cells to die. Healthy cells are less affected because they have other ways to repair their DNA. This targeted action is what makes PARP inhibitors like Lynparza effective. It specifically targets the cancer cells’ ability to survive and grow.
Who is Lynparza for?
Lynparza is for adults with specific types of cancer linked to certain gene mutations. Your doctor will perform tests to see if this drug is right for you. It is prescribed for advanced ovarian cancer as a maintenance therapy. It also treats metastatic breast cancer with HER2-negative and BRCA mutations. For pancreatic cancer, it can treat metastatic cases with gBRCA mutations. Finally, it treats metastatic castration-resistant prostate cancer in men with certain genetic profiles who have tried other hormonal treatments.
Dosage and administration
Lynparza dosage is determined by your doctor based on your condition. The standard dose is typically 300 mg, which is two 150 mg tablets. You should take the tablets twice a day, once in the morning and once at night. Swallow the tablets whole with or without food. Do not chew, crush, or split the tablets. Doing so can change how the medication works in your body. Always follow your doctor’s instructions carefully for the best results. If you miss a dose, take the next one at its regular time.
Side effects
Lynparza may cause side effects, which can range from mild to severe. Common side effects include nausea, fatigue, and changes in appetite. You might also experience headaches, dizziness, or diarrhea. More serious side effects can also occur. These include a drop in blood cell counts, which can lead to anemia. This may cause tiredness, pale skin, and shortness of breath. Allergic reactions are rare but serious. Tell your doctor about any side effects you experience. They can help you manage them effectively.
Why buy from IsraelPharm?
IsraelPharm offers a reliable and convenient way to purchase your medications. We provide access to authentic brand-name drugs like Lynparza at competitive prices. Our licensed pharmacists are available to answer your questions. We ensure your privacy and provide discreet shipping directly to your home. With our easy-to-use online platform, managing your prescription needs is simple. We are committed to providing excellent customer service and care. Choose IsraelPharm for a trustworthy and affordable pharmacy experience.
Lynparza can cause side effects. Some may be serious. You should always discuss potential side effects with your doctor.
Common Side Effects
Many patients experience mild to moderate side effects. Consult your doctor if these persist.
- Nausea or vomiting
- Tiredness or fatigue
- Indigestion or heartburn
- Loss of appetite
- Headache
- Changes in taste
- Dizziness
- Cough or shortness of breath
- Diarrhea
Serious Side Effects
Seek medical attention immediately if you experience signs of a serious problem. These can include low blood cell counts or severe allergic reactions.
- Signs of anemia (low red blood cells) like extreme tiredness, pale skin, or a fast heartbeat.
- Swelling of the face, tongue, or throat.
- Difficulty breathing or wheezing.
- Skin reactions like hives, rash, blistering, or peeling.
Lynparza is indicated for patients with specific genetic mutations for the treatment of several types of cancer:
- Ovarian Cancer: Used as a maintenance treatment after initial chemotherapy for advanced ovarian cancer. It is also used with bevacizumab for HRD-positive advanced ovarian cancer.
- Breast Cancer: Treats metastatic HER2-negative breast cancer with BRCA mutations. It is also for high-risk early breast cancer with gBRCAm mutations post-chemotherapy.
- Pancreatic Cancer: Serves as maintenance treatment for gBRCAm metastatic pancreatic cancer if the disease has not progressed after chemotherapy.
- Prostate Cancer: Treats metastatic castration-resistant prostate cancer (mCRPC) with specific gene mutations after other treatments have failed.